Bupropion -hydrobromid
CAS: 905818-69-1
Ref. 3D-FLB81869
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar | |
| 250mg | A consultar | |
| 500mg | A consultar |
Informação sobre produto
- 1-Propanone, 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-, hydrobromide
- 1-Propanone, 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-, hydrobromide (1:1)
- 2-(Tert-Butylamino)-1-(3-Chlorophenyl)Propan-1-One Hydrobromide (1:1)
- Amfebutamone Hydrobromide
- Unii-E70G3G5863
Bupropion is a drug that inhibits dopamine reuptake and is used for the treatment of depression, attention-deficit hyperactivity disorder, and seasonal affective disorder. It is also used to help people stop smoking. Bupropion has been shown to have a low oral bioavailability due to its hydrophobic properties. This drug binds to the dopamine transporter in the brain and reduces the rate of dopamine uptake by neurons. The half-life of bupropion ranges from 16 hours to 27 hours, which makes it suitable for once-daily dosing. Bupropion appears to be an inhibitor of monoamine oxidase A (MAO-A) as well as an antagonist at nicotinic acetylcholine receptors in certain brain regions, leading to its antidepressant effects.
Bupropion can be administered orally in tablet or capsule form or as an intramuscular injection. It can also be administered intravenously but this route is not recommended because of bu
Propriedades químicas
Consulta técnica sobre: 3D-FLB81869 Bupropion -hydrobromid
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
